An expanding universe of the non-coding genome in cancer biology

Carcinogenesis

Volumn 35, Issue 6, 2014, Pages 1209-1216

  Xue, Bin ^a   He, Lin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA; MICRORNA; PIWI INTERACTING RNA; SMALL INTERFERING RNA; SMALL UNTRANSLATED RNA; UNTRANSLATED RNA;

CANCER GENETICS; CHROMOSOME REARRANGEMENT; COLON CANCER; COLON POLYPOSIS; COLORECTAL CANCER; DISEASE COURSE; GENE CONTROL; GENE EXPRESSION REGULATION; GENOME; HUMAN; LIVER CELL CARCINOMA; LUNG CANCER; MALIGNANT TRANSFORMATION; NONHUMAN; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RETROPOSON; REVIEW; RNA TRANSCRIPTION; RNA TRANSLATION; TUMOR SUPPRESSOR GENE; ANIMAL; CELL TRANSFORMATION; GENETICS; METABOLISM; NEOPLASM;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GENOME; GENOME COMPONENTS; HUMANS; MICRORNAS; NEOPLASMS; ONCOGENES; RETROELEMENTS; RNA, UNTRANSLATED;

EID: 84905403917     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu099     Document Type: Review

References (126)

1. Batista, P.J. et al. (2013) Long noncoding RNAs: cellular address codes in development and disease. Cell, 152, 1298-1307.
2. Cordaux, R. et al. (2009) The impact of retrotransposons on human genome evolution. Nat. Rev. Genet., 10, 691-703.
3. Goodier, J.L. et al. (2008) Retrotransposons revisited: the restraint and rehabilitation of parasites. Cell, 135, 23-35.
4. Licatalosi, D.D. et al. (2010) RNA processing and its regulation: global insights into biological networks. Nat. Rev. Genet., 11, 75-87.
5. Rinn, J.L. et al. (2012) Genome regulation by long noncoding RNAs. Annu. Rev. Biochem., 81, 145-166.
6. He, L. et al. (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet., 5, 522-531.
7. Lee, Y. et al. (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature, 425, 415-419.
8. Lee, Y.S. et al. (2004) Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways. Cell, 117, 69-81.
9. Hutvágner, G. et al. (2002) A microRNA in a multiple-turnover RNAi enzyme complex. Science, 297, 2056-2060.
10. Bartel, D.P. (2009) MicroRNAs: target recognition and regulatory functions. Cell, 136, 215-233.
11. Tuschl, T. et al. (1999) Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev., 13, 3191-3197.
12. Hammond, S.M. et al. (2000) An RNA-directed nuclease mediates posttranscriptional gene silencing in Drosophila cells. Nature, 404, 293-296.
13. Pillai, R.S. et al. (2005) Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science, 309, 1573-1576.
14. Zhang, L. et al. (2006) microRNAs exhibit high frequency genomic alterations in human cancer. Proc. Natl Acad. Sci. USA, 103, 9136-9141.
15. He, L. et al. (2005) A microRNA polycistron as a potential human oncogene. Nature, 435, 828-833.
16. Macfarlane, L.-A. et al. (2010) MicroRNA: biogenesis, function and role in cancer. Curr. Genomics, 11, 537-561.
17. Esquela-Kerscher, A. et al. (2006) Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer, 6, 259-269.
18. Mendell, J.T. et al. (2012) MicroRNAs in stress signaling and human disease. Cell, 148, 1172-1187.
19. Macfarlan, T.S. et al. (2012) Embryonic stem cell potency fluctuates with endogenous retrovirus activity. Nature, 487, 57-63.
20. Lu, X. et al. (2014) The retrovirus HERVH is a long noncoding RNA required for human embryonic stem cell identity. Nat. Struct. Mol. Biol., 21, 423-425.
21. Stocking, C. et al. (2008) Murine endogenous retroviruses. Cell. Mol. Life Sci., 65, 3383-3398.
22. Lander, E.S. et al. (2001) Initial sequencing and analysis of the human genome. Nature, 409, 860-921.
23. Beck, C.R. et al. (2011) LINE-1 elements in structural variation and disease. Annu. Rev. Genomics Hum. Genet., 12, 187-215.
24. Huang, C.R. et al. (2010) Mobile interspersed repeats are major structural variants in the human genome. Cell, 141, 1171-1182.
25. Wang, H. et al. (2005) SVA elements: a hominid-specific retroposon family. J. Mol. Biol., 354, 994-1007.
26. Miki, Y. et al. (1992) Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res., 52, 643-645.
27. Solyom, S. et al. (2012) Extensive somatic L1 retrotransposition in colorectal tumors. Genome Res., 22, 2328-2338.
28. Lee, E. et al. (2012) Landscape of somatic retrotransposition in human cancers. Science, 337, 967-971.
29. Bock, C. et al. (2006) CpG island methylation in human lymphocytes is highly correlated with DNA sequence, repeats, and predicted DNA structure. PLoS Genet., 2, e26.
30. Das, R. et al. (2006) Computational prediction of methylation status in human genomic sequences. Proc. Natl Acad. Sci. USA, 103, 10713-10716.
31. Maksakova, I.A. et al. (2008) Keeping active endogenous retroviral-like elements in check: the epigenetic perspective. Cell. Mol. Life Sci., 65, 3329-3347.
32. Aravin, A.A. et al. (2007) Developmentally regulated piRNA clusters implicate MILI in transposon control. Science, 316, 744-747.
33. Ciaudo, C. et al. (2013) RNAi-dependent and independent control of LINE1 accumulation and mobility in mouse embryonic stem cells. PLoS Genet., 9, e1003791.
34. Brunmeir, R. et al. (2010) Epigenetic regulation of a murine retrotransposon by a dual histone modification mark. PLoS Genet., 6, e1000927.
35. Dunican, D.S. et al. (2013) Lsh regulates LTR retrotransposon repression independently of Dnmt3b function. Genome Biol., 14, R146.
36. Fadloun, A. et al. (2013) Chromatin signatures and retrotransposon profiling in mouse embryos reveal regulation of LINE-1 by RNA. Nat. Struct. Mol. Biol., 20, 332-338.
37. Kuramochi-Miyagawa, S. et al. (2008) DNA methylation of retrotransposon genes is regulated by Piwi family members MILI and MIWI2 in murine fetal testes. Genes Dev., 22, 908-917.
38. Reichmann, J. et al. (2012) Microarray analysis of LTR retrotransposon silencing identifies Hdac1 as a regulator of retrotransposon expression in mouse embryonic stem cells. PLoS Comput. Biol., 8, e1002486.
39. Estécio, M.R. et al. (2010) Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancer. Genome Res., 20, 1369-1382.
40. Robertson, K.D. (2005) DNA methylation and human disease. Nat. Rev. Genet., 6, 597-610.
41. Liu, W.M. et al. (1995) Cell stress and translational inhibitors transiently increase the abundance of mammalian SINE transcripts. Nucleic Acids Res., 23, 1758-1765.
42. Stribinskis, V. et al. (2006) Activation of human long interspersed nuclear element 1 retrotransposition by benzo(a)pyrene, an ubiquitous environmental carcinogen. Cancer Res., 66, 2616-2620.
43. Teneng, I. et al. (2011) Reactivation of L1 retrotransposon by benzo(a)pyrene involves complex genetic and epigenetic regulation. Epigenetics, 6, 355-367.
44. Feng, Q. et al. (1996) Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell, 87, 905-916.
45. Mathias, S.L. et al. (1991) Reverse transcriptase encoded by a human transposable element. Science, 254, 1808-1810.
46. Khazina, E. et al. (2011) Trimeric structure and flexibility of the L1ORF1 protein in human L1 retrotransposition. Nat. Struct. Mol. Biol., 18, 1006-1014.
47. Kolosha, V.O. et al. (1997) In vitro properties of the first ORF protein from mouse LINE-1 support its role in ribonucleoprotein particle formation during retrotransposition. Proc. Natl Acad. Sci. USA. 94, 10155-10160.
48. Szak, S. et al. (2002) Molecular archeology of L1 insertions in the human genome. Genome Biol., 3, research0052.1-research0052.18.
49. Moran, J.V. et al. (1999) Exon shuffling by L1 retrotransposition. Science, 283, 1530-1534.
50. Rangwala, S.H. et al. (2009) Many LINE1 elements contribute to the transcriptome of human somatic cells. Genome Biol., 10, R100.
51. Speek, M. (2001) Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes. Mol. Cell. Biol., 21, 1973-1985.
52. Brouha, B. et al. (2003) Hot L1s account for the bulk of retrotransposition in the human population. Proc. Natl Acad. Sci. USA, 100, 5280-5285.
53. Sassaman, D.M. et al. (1997) Many human L1 elements are capable of retrotransposition. Nat. Genet., 16, 37-43.
54. Amariglio, E.N. et al. (1991) Identity of rearranged LINE/c-MYC junction sequences specific for the canine transmissible venereal tumor. Proc. Natl Acad. Sci. USA, 88, 8136-8139.
55. Katzir, N. et al. (1985) "Retroposon" insertion into the cellular oncogene c-myc in canine transmissible venereal tumor. Proc. Natl Acad. Sci. USA, 82, 1054-1058.
56. Murgia, C. et al. (2006) Clonal origin and evolution of a transmissible cancer. Cell, 126, 477-487.
57. Ewing, A.D. et al. (2010) High-throughput sequencing reveals extensive variation in human-specific L1 content in individual human genomes. Genome Res. 20, 1262-1270.
58. Iskow, R.C. et al. (2010) Natural mutagenesis of human genomes by endogenous retrotransposons. Cell, 141, 1253-1261.
59. Shukla, R. et al. (2013) Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma. Cell, 153, 101-111.
60. Thomas, C.A. et al. (2012) LINE-1 retrotransposition in the nervous system. Annu. Rev. Cell Dev. Biol., 28, 555-573.
61. Deininger, P.L. et al. (1999) Alu repeats and human disease. Mol. Genet. Metab., 67, 183-193.
62. Batzer, M.A. et al. (2002) Alu repeats and human genomic diversity. Nat. Rev. Genet., 3, 370-379.
63. Deininger, P.L. et al. (2002) Mammalian retroelements. Genome Res., 12, 1455-1465.
64. Bennett, E.A. et al. (2008) Active Alu retrotransposons in the human genome. Genome Res., 18, 1875-1883.
65. Zhang, W. et al. (2011) Alu distribution and mutation types of cancer genes. BMC Genomics, 12, 157.
66. Watanabe, M. et al. (2005) Founder SVA retrotransposal insertion in Fukuyama-type congenital muscular dystrophy and its origin in Japanese and Northeast Asian populations. Am. J. Med. Genet. A, 138, 344-348.
67. Conley, M.E. et al. (2005) Two independent retrotransposon insertions at the same site within the coding region of BTK. Hum. Mutat., 25, 324-325.
68. Chen, J.M. et al. (2010) Genomic rearrangements in inherited disease and cancer. Semin. Cancer Biol., 20, 222-233.
69. Hastings, P.J. et al. (2009) Mechanisms of change in gene copy number. Nat. Rev. Genet., 10, 551-564.
70. Kvikstad, E.M. et al. (2010) The (r)evolution of SINE versus LINE distributions in primate genomes: sex chromosomes are important. Genome Res., 20, 600-613.
71. Abrusán, G. et al. (2006) The distribution of L1 and Alu retroelements in relation to GC content on human sex chromosomes is consistent with the ectopic recombination model. J. Mol. Evol., 63, 484-492.
72. Smith, T.M. et al. (1996) Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res., 6, 1029-1049.
73. Puget, N. et al. (2002) Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot. Am. J. Hum. Genet., 70, 858-865.
74. Puget, N. et al. (1997) A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17. Cancer Res., 57, 828-831.
75. Peixoto, A. et al. (2013) Genomic characterization of two large Alumediated rearrangements of the BRCA1 gene. J. Hum. Genet., 58, 78-83.
76. Bannert, N. et al. (2004) Retroelements and the human genome: new perspectives on an old relation. Proc. Natl Acad. Sci. USA, 101, 14572-14579.
77. Shin, W. et al. (2013) Human-specific HERV-K insertion causes genomic variations in the human genome. PLoS One, 8, e60605.
78. Hughes, J.F. et al. (2001) Evidence for genomic rearrangements mediated by human endogenous retroviruses during primate evolution. Nat. Genet., 29, 487-489.
79. Barahona, A. (1997) Barbara McClintock and the transposition concept. Arch. Int. Hist. Sci. (Paris)., 46, 309-329.
80. Wang, T. et al. (2007) Species-specific endogenous retroviruses shape the transcriptional network of the human tumor suppressor protein p53. Proc. Natl Acad. Sci. USA, 104, 18613-18618.
81. Bourque, G. et al. (2008) Evolution of the mammalian transcription factor binding repertoire via transposable elements. Genome Res., 18, 1752-1762.
82. Ponicsan, S.L. et al. (2010) Genomic gems: SINE RNAs regulate mRNA production. Curr. Opin. Genet. Dev., 20, 149-155.
83. Han, J.S. et al. (2004) Transcriptional disruption by the L1 retrotransposon and implications for mammalian transcriptomes. Nature, 429, 268-274.
84. Yelin, R. et al. (2003) Widespread occurrence of antisense transcription in the human genome. Nat. Biotechnol., 21, 379-386.
85. Carninci, P. et al. (2005) The transcriptional landscape of the mammalian genome. Science, 309, 1559-1563.
86. Faulkner, G.J. et al. (2009) The regulated retrotransposon transcriptome of mammalian cells. Nat. Genet., 41, 563-571.
87. Irvin-Wilson, C.V. et al. (2005) Alternative initiation and splicing in dicer gene expression in human breast cells. Breast Cancer Res., 7, R563-R569.
88. Singer, G.A. et al. (2008) Genome-wide analysis of alternative promoters of human genes using a custom promoter tiling array. BMC Genomics, 9, 349.
89. Thorsen, K. et al. (2011) Tumor-specific usage of alternative transcription start sites in colorectal cancer identified by genome-wide exon array analysis. BMC Genomics, 12, 505.
90. Wolff, E.M. et al. (2010) Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. PLoS Genet., 6, e1000917.
91. Pagani, F. et al. (2004) Genomic variants in exons and introns: identifying the splicing spoilers. Nat. Rev. Genet., 5, 389-396.
92. Castle, J.C. et al. (2008) Expression of 24, 426 human alternative splicing events and predicted cis regulation in 48 tissues and cell lines. Nat. Genet., 40, 1416-1425.
93. Wang, E.T. et al. (2008) Alternative isoform regulation in human tissue transcriptomes. Nature, 456, 470-476.
94. Shen, S. et al. (2011) Widespread establishment and regulatory impact of Alu exons in human genes. Proc. Natl Acad. Sci. USA, 108, 2837-2842.
95. Athanasiadis, A. et al. (2004) Widespread A-to-I RNA editing of Alucontaining mRNAs in the human transcriptome. PLoS Biol., 2, e391.
96. Van de Lagemaat, L.N. et al. (2006) Multiple effects govern endogenous retrovirus survival patterns in human gene introns. Genome Biol. 7, R86.
97. Eswaran, J. et al. (2013) RNA sequencing of cancer reveals novel splicing alterations. Sci. Rep., 3, 1689.
98. Zhang, J. et al. (2013) Misregulation of pre-mRNA alternative splicing in cancer. Cancer Discov., 3, 1228-1237.
99. Watson, I.R. et al. (2013) Emerging patterns of somatic mutations in cancer. Nat. Rev. Genet., 14, 703-718.
100. David, C.J. et al. (2010) Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev. 24, 2343-2364.
101. Linker, S. et al. (2013) Linear decay of retrotransposon antisense bias across genes is contingent upon tissue specificity. PLoS One, 8, e79402.
102. Ling, J. et al. (2002) The solitary long terminal repeats of ERV-9 endogenous retrovirus are conserved during primate evolution and possess enhancer activities in embryonic and hematopoietic cells. J. Virol., 76, 2410-2423.
103. Pi, W. et al. (2010) Long-range function of an intergenic retrotransposon. Proc. Natl Acad. Sci. USA, 107, 12992-12997.
104. Cruickshanks, H.A. et al. (2013) Expression of a large LINE-1-driven antisense RNA is linked to epigenetic silencing of the metastasis suppressor gene TFPI-2 in cancer. Nucleic Acids Res., 41, 6857-6869.
105. Smalheiser, N.R. et al. (2005) Mammalian microRNAs derived from genomic repeats. Trends Genet., 21, 322-326.
106. Gogvadze, E. et al. (2009) Human-specific modulation of transcriptional activity provided by endogenous retroviral insertions. J. Virol., 83, 6098-6105.
107. Greaves, M. et al. (2012) Clonal evolution in cancer, Nature, 481, 306-313.
108. Perkel, J.M. (2013) Visiting "noncodarnia". Biotechniques, 54, 301, 303-304.
109. Carninci, P. et al. (2005) The transcriptional landscape of the mammalian genome. Science, 309, 1559-1563.
110. Wang, K.C. et al. (2011) Molecular mechanisms of long noncoding RNAs. Mol. Cell, 43, 904-914.
111. Ji, P. et al. (2003) MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene, 22, 8031-8041.
112. Gibb, E.A. et al. (2011) The functional role of long non-coding RNA in human carcinomas. Mol. Cancer, 10, 38.
113. Huarte, M. et al. (2010) A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell, 142, 409-419.
114. Yildirim, E. et al. (2013) Xist RNA is a potent suppressor of hematologic cancer in mice. Cell, 152, 727-742.
115. Ganesan, S. et al. (2002) BRCA1 supports XIST RNA concentration on the inactive X chromosome. Cell, 111, 393-405.
116. Yu, W. et al. (2008) Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature, 451, 202-206.
117. Mighell, A.J. et al. (2000) Vertebrate pseudogenes. FEBS Lett., 468, 109-114.
118. Balakirev, E.S. et al. (2003) Pseudogenes: are they "junk" or functional DNA? Annu. Rev. Genet., 37, 123-151.
119. Nie, L. et al. (2012) Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer. Am. J. Transl. Res., 4, 127-150.
120. Pei, B. et al. (2012) The GENCODE pseudogene resource. Genome Biol., 13, R51.
121. Patnala, R. et al. (2014) Inhibition of LINE-1 retrotransposonencoded reverse transcriptase modulates the expression of cell differentiation genes in breast cancer cells. Breast Cancer Res. Treat., 143, 239-253.
122. Salmena, L. et al. (2011) A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell, 146, 353-358.
123. Sumazin, P. et al. (2011) An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma. Cell, 147, 370-381.
124. Poliseno, L. et al. (2010) A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature, 465, 1033-1038.
125. Hawkins, P.G. et al. (2010) Transcriptional regulation of Oct4 by a long noncoding RNA antisense to Oct4-pseudogene 5. Transcription, 1, 165-175.
126. Duret, L. et al. (2006) The Xist RNA gene evolved in eutherians by pseudogenization of a protein-coding gene. Science, 312, 1653-1655.